ES2000842A6 - Un procedimiento para la preparacion de analogos semisinteticos de compactina y mevinolina - Google Patents

Un procedimiento para la preparacion de analogos semisinteticos de compactina y mevinolina

Info

Publication number
ES2000842A6
ES2000842A6 ES8600874A ES8600874A ES2000842A6 ES 2000842 A6 ES2000842 A6 ES 2000842A6 ES 8600874 A ES8600874 A ES 8600874A ES 8600874 A ES8600874 A ES 8600874A ES 2000842 A6 ES2000842 A6 ES 2000842A6
Authority
ES
Spain
Prior art keywords
hydrogen
reductase inhibitors
image
coa reductase
hmg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8600874A
Other languages
English (en)
Inventor
William F Hoffman
Robert L Smith
Edward Scolnick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of ES2000842A6 publication Critical patent/ES2000842A6/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings

Abstract

SE DESCRIBE UN PROCEDIMIENTO PARA LA PREPARACION DE ANALOGOS SEMISINTETICOS DE COMPACTINA Y MEVINOLINA, QUE SON NUEVOS INHIBIDORES DE 3-HIDROXI-3-METILGLUTARILCOENZIMA A (HMG-GA) REDUCTASA, UTILES COMO AGENTES ANTIHIPERCOLESTEROLEMICOS Y ESTAN REPRESENTADOS POR LAS FORMULAS ESTRUCTURALES GENERALES (I) O (II) DESCRITAS EN LA MEMORIA DONDE: N ES 1 A 5; R ES HIDROGENO O (ALQUILO C1-5)C-; R1 ES HIDROGENO O METILO; R2 ES HIDROGENO O METILO; Y R3 ES HIDROGENO, ALQUILO C1-5 O ALQUILO C1-5 SUSTITUIDO CON UN MIEMBRO DEL GRUPO FORMADO POR FENILO, DIMETILAMINO O ACETILAMINO Y LAS LINEAS DE PUNTOS EN A, B Y C REPRESENTAN DOBLES ENLACES OPCIONALES Y LAS SALES FARMACEUTICAMENTE ACEPTABLES DE LOS COMPUESTOS (II) DONDE R3 ES HIDROGENO, MEDIANTE EL TRATAMIENTO DE UN COMPUESTO DE FORMULA (4), DESCRITO EN LA MEMORIA, CON UN HALURO DE TETRA(ALQUIL C1-5)AMONIO Y UN ACIDO ORGANICO, SEGUIDO DE POSTERIOR CONVERSION PARA OBTENER LOS PRODUCTOS FINALES DESEADOS.
ES8600874A 1985-08-05 1986-08-05 Un procedimiento para la preparacion de analogos semisinteticos de compactina y mevinolina Expired ES2000842A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/762,736 US4668699A (en) 1985-08-05 1985-08-05 Novel HMG-CoA reductase inhibitors

Publications (1)

Publication Number Publication Date
ES2000842A6 true ES2000842A6 (es) 1988-03-16

Family

ID=25065902

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8600874A Expired ES2000842A6 (es) 1985-08-05 1986-08-05 Un procedimiento para la preparacion de analogos semisinteticos de compactina y mevinolina

Country Status (13)

Country Link
US (2) US4668699A (es)
EP (1) EP0211416B1 (es)
JP (1) JPS6233133A (es)
KR (1) KR870002158A (es)
AU (1) AU6084686A (es)
CA (1) CA1291143C (es)
DE (1) DE3681991D1 (es)
DK (1) DK370486A (es)
ES (1) ES2000842A6 (es)
GR (1) GR862006B (es)
IL (1) IL79530A0 (es)
PT (1) PT83077B (es)
ZA (1) ZA865779B (es)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3682557D1 (de) * 1985-09-13 1992-01-02 Sankyo Co Hydroxy-ml-236b-derivate, deren herstellung und anwendung.
US4916162A (en) * 1986-05-05 1990-04-10 Merck & Co., Inc. Antihypercholesterolemic compounds
USRE36481E (en) * 1986-06-23 2000-01-04 Merck & Co., Inc. HMG-CoA reductase inhibitors
US4940727A (en) * 1986-06-23 1990-07-10 Merck & Co., Inc. Novel HMG-CoA reductase inhibitors
US5116870A (en) * 1986-06-23 1992-05-26 Merck & Co., Inc. HMG-CoA reductase inhibitors
US4789682A (en) * 1987-03-17 1988-12-06 Merck & Co., Inc. Antihypercholesterolemic compounds
US4845237A (en) * 1987-04-15 1989-07-04 Merck & Co., Inc. Acylation process for the synthesis of HMG-CoA reductase inhibitors
PT88364A (pt) * 1987-09-02 1989-07-31 Merck & Co Inc Process for preparing novel hmg-coa reductase inhibitors
US4939143A (en) * 1987-12-21 1990-07-03 Rorer Pharmaceutical Corporation Substituted cyclohexene derivatives as HMG-CoA reductase inhibitors
US4900754A (en) * 1987-12-21 1990-02-13 Rorer Pharmaceutical Corp. HMG-COA reductase inhibitors
US4904692A (en) * 1987-12-21 1990-02-27 Rorer Pharmaceutical Corporation Novel HMG-CoA reductase inhibitors
US4994494A (en) * 1987-12-21 1991-02-19 Rhone-Poulenc Rorer Pharmaceuticals Inc. HMG-COA reductase inhibitors
US5001128A (en) * 1987-12-21 1991-03-19 Rhone-Poulenc Rorer Pharmaceuticals Inc. HMG-COA reductase inhibitors
US4892884A (en) * 1987-12-21 1990-01-09 Rorer Pharmaceutical Corporation Novel hmg-coa reductase inhibitors
US4904691A (en) * 1987-12-21 1990-02-27 Rorer Pharmaceutical Corporation Novel HMG-CoA reductase inhibitors
US5001144A (en) * 1987-12-21 1991-03-19 Rhone-Poulenc Rorer Pharmaceuticals Inc. Substituted cyclohexene derivatives as HMG-CoA reductase inhibitors
US4857546A (en) * 1988-01-07 1989-08-15 Merck & Co., Inc. Novel HMG-CoA reductase inhibitors
US4857547A (en) * 1988-01-07 1989-08-15 Merck & Co., Inc. Novel HMG-CoA reductase inhibitors
US4866068A (en) * 1988-02-01 1989-09-12 Merck & Co., Inc. Novel HMG-CoA reductase inhibitors
US5049696A (en) * 1988-04-11 1991-09-17 Merck & Co., Inc. Antihypercholesterolemic compounds
FI893004A (fi) * 1988-06-29 1989-12-30 Merck & Co Inc 5-oxygenerade hmg-coa-reduktas -inhibitorer.
US5075327A (en) * 1988-08-10 1991-12-24 Hoffmann-La Roche Inc. Antipsoriatic agents
US5073568A (en) * 1988-11-14 1991-12-17 Hoffmann-La Roche Inc. Antipsoriatic agents
US5021451A (en) * 1988-11-14 1991-06-04 Hoffman-La Roche Inc. Method for inhibiting hyperproliferative diseases
US5200549A (en) * 1988-11-14 1993-04-06 Hoffman-La Roche Inc. Antipsoriatic agents
US5130306A (en) * 1989-03-13 1992-07-14 Merck & Co., Inc. 5-Oxygenated HMG-COA reductase inhibitors
US5132312A (en) * 1989-03-27 1992-07-21 Rhone-Poulenc Rorer Pharmaceuticals Inc. Substituted cyclohexene derivatives as HMG-CoA reductase inhibitors
IL90847A0 (en) * 1989-06-09 1990-02-09 Merck & Co Inc 3-keto hmg-coa reductase inhibitors and pharmaceutical compositions containing them
GB8915280D0 (en) * 1989-07-04 1989-08-23 British Bio Technology Compounds
FI94339C (fi) 1989-07-21 1995-08-25 Warner Lambert Co Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
US4992429A (en) * 1989-08-24 1991-02-12 Rhone-Poulenc Rorer Pharmaceuticals Inc. Novel HMG-COA reductase inhibitors
EP0415188B1 (en) * 1989-08-28 1996-03-20 F. Hoffmann-La Roche Ag Enzymatic method for determining analyte concentrations
US4946860A (en) * 1989-11-03 1990-08-07 Rorer Pharmaceutical Corporation Benzothiopyranyl derivatives as HMG-CoA reductase inhibitors
US6630502B2 (en) 1990-05-15 2003-10-07 E.R. Squibb & Sons, Inc. Method for preventing, stabilizing or causing regression of atherosclerosis employing a combination of a cholesterol lowering drug and an ace inhibitor
GB9100174D0 (en) * 1991-01-04 1991-02-20 British Bio Technology Compounds
IL108432A (en) * 1993-01-29 1997-09-30 Sankyo Co DERIVATIVES OF 3, 5-DIHYDROXY-7- £1, 2, 6, 7, 8, 8a-HEXAHYDRO-2- METHYL-8- (SUBSTITUTED ALKANOYLOXY)-1-NAPHTHYL| HEPTANOIC ACID AND THEIR LACTONES, THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
GB0003305D0 (en) 2000-02-15 2000-04-05 Zeneca Ltd Pyrimidine derivatives
JP2003012607A (ja) * 2001-06-26 2003-01-15 Mercian Corp 新規なメバスタチン誘導体
AU2002366444A1 (en) * 2001-11-08 2003-09-09 Merck & Co., Inc. Compounds useful in the treatment of anthrax
JP4615309B2 (ja) 2002-05-17 2011-01-19 オセラ・ホールディング・インコーポレイテッド 白内障および他の眼球疾患の進行の改善
US20040119052A1 (en) * 2002-12-20 2004-06-24 Beavers William Anthony Process for preparing alpha- and beta- methyl-gamma-butyrolactone and 3-methyltetrahydrofuran
US7825134B2 (en) * 2003-05-19 2010-11-02 Othera Holding, Inc. Amelioration of cataracts, macular degeneration and other ophthalmic diseases
WO2007020079A2 (en) * 2005-08-17 2007-02-22 Synthon B.V. Orally disintegratable simvastatin tablets
WO2012100835A1 (en) 2011-01-28 2012-08-02 Laboratorios Del Dr. Esteve, S.A. Methods and compositions for the treatment of aids
EA026148B1 (ru) * 2012-06-05 2017-03-31 ДСМ АйПи АССЕТС Б.В. Способ получения 4-алканоилокси-2-метилбутановой кислоты
EP3638044B1 (en) * 2017-06-15 2024-03-13 DSM IP Assets B.V. Frozen enzyme pellets
CN111225672B (zh) 2017-10-16 2023-09-29 清华大学 甲羟戊酸通路抑制剂及其药物组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2748825C2 (de) * 1976-11-02 1986-11-27 Sankyo Co., Ltd., Tokio/Tokyo Substituierte 3,5-Dihydroxyheptansäurederivate und diese enthaltende Arzneimittel gegen Hyperlipämie
AU548996B2 (en) * 1980-02-04 1986-01-09 Merck & Co., Inc. Tetrahydro-2h-pyran-2-one derivatives
MX7065E (es) * 1980-06-06 1987-04-10 Sankyo Co Un procedimiento microbiologico para preparar derivados de ml-236b
US4376863A (en) * 1981-08-21 1983-03-15 Merck & Co., Inc. Hypocholesterolemic fermentation products
JPS5835144A (ja) * 1981-08-27 1983-03-01 Sankyo Co Ltd Ｍｂ−５３０ｂ誘導体およびその製造法
EP0094443A1 (en) * 1982-05-17 1983-11-23 Merck & Co. Inc. 6(R)-(2-(8(S) (2,2-dimethylbutyryloxy)-2(S),6(S)-dimethyl-1,2,3,4,4a(S),5,6,7,8,8a(S)-decahydronaphthyl-1(S))ethyl)-4(R)-hydroxy-3,4,5,6-tetrahydro-2H-pyran-2-one, process for preparing and pharmaceutical composition containing the same
JPS59122483A (ja) * 1982-12-28 1984-07-14 Nippon Chemiphar Co Ltd 新規なモナコリン誘導体
DE3480923D1 (de) * 1983-10-11 1990-02-08 Merck & Co Inc Verfahren zur c-methylierung von 2-methylbutyraten.
JPH09122483A (ja) * 1995-10-31 1997-05-13 Matsushita Electric Ind Co Ltd 窒素酸化物・硫黄酸化物吸収剤

Also Published As

Publication number Publication date
IL79530A0 (en) 1986-11-30
ZA865779B (en) 1987-03-25
EP0211416A3 (en) 1987-09-23
PT83077B (en) 1988-07-13
US4851436A (en) 1989-07-25
JPS6233133A (ja) 1987-02-13
EP0211416B1 (en) 1991-10-16
CA1291143C (en) 1991-10-22
GR862006B (en) 1986-12-23
EP0211416A2 (en) 1987-02-25
DE3681991D1 (de) 1991-11-21
DK370486D0 (da) 1986-08-04
AU6084686A (en) 1987-02-12
KR870002158A (ko) 1987-03-30
PT83077A (en) 1986-08-01
US4668699A (en) 1987-05-26
DK370486A (da) 1987-02-06

Similar Documents

Publication Publication Date Title
ES2000842A6 (es) Un procedimiento para la preparacion de analogos semisinteticos de compactina y mevinolina
DK51087A (da) Antihypercholesterolaemiske forbindelser
TW268952B (es)
EE03194B1 (et) Ühendid, nende kasutamine magustavate toimeainetena ja nende valmistamise meetod
ES2058653T3 (es) Inhibidor de proteinasas.
AU5027393A (en) Benzo-fused lactams
FI952014A (fi) Uusia bisyklisiä merkaptoasetyyliamidilaktaamijohdannaisia, jotka ovat hyödyllisiä enkefalinaasin ja ACE:n inhibiittoreina
ES2021182A6 (es) Procedimiento para preparar derivados de capsaicina.
ATE226210T1 (de) Phospholipidanaloge verbindungen
DE69326302T2 (de) Pleuromutilin-derivate
MY132329A (en) [(3-alkoxy-phenoxy)-ethyl] - dialkylamine derivatives and their use as local anaesthetics
ES2087247T3 (es) Inhibidor de aldosa reductasa.
IL90781A0 (en) 5-oxygenated hmg-coa reductase inhibitors and pharmaceutical compositions containing them
EP0245990A3 (en) Antihypercholesterolemic compounds
EP0245003A3 (en) Antihypercholesterolemic compounds
TR199802456T2 (xx) Yeni pirol t�revleri.
KR930017886A (ko) 알도오스 환원효소 저해물질
DE69405760T2 (de) 4-aza-pregnan-5-alpha-reductase isozym 1 inhibitoren
EP0245004A3 (en) Antihypercholesterolemic compounds
GB9324931D0 (en) Glutaramide derivatives
WO1995002603A3 (en) Use of cephem derivatives as anti-metastatic agents
AU9426098A (en) Azetidinone derivatives for the treatment of hcmv infections
AU3350195A (en) Bicyclic carboxamides as 5-HT-1A antagonists
ITMI911855A1 (it) Procedimento per la preparazione di biciclo (3. 2. 0) ept-2-en-7-oni
FI956334A (fi) Farmakologisesti aktiivisia enantiomeereja